Table S1.

Fold changes of mRNA in sham-treated vs. contralateral brain

q2 mRNA	0.5 h	6 h	12 h
Adm	1.8	0.96	0.82
Agt	0.72	1.15	0.69
Akt1	0.8	0.76	0.95
Aldh3a2	0.78	0.74	0.84
Bcl2a1	0.71	0.77	1.12
Bcl2l1	0.91	0.71	0.87
Birc2	0.45	0.82	0.95
Birc3	0.99	0.98	0.71
C3	1.1	0.65	0.85
C4a	2.26	0.62	0.95
Ccl11	0.68	0.33	1
Ccl12	0.56	2.47	1.17
Ccl22	0.45	1.23	1.6
Ccl5	0.49	0.98	0.85
Ccnd1	0.31	0.85	0.73
Ccr5	0.02	0.77	0.96
Cd40	0.46	1.05	0.88
Cd74	0.2	0.6	0.56
Cd80	0.34	0.63	1.05
Cd83	0.69	1.35	1
Cdkn1a	0.53	1.51	1.8
Cfb	1.21	0.71	0.84
Csf1	1.13	0.81	0.81
Csf2	0.85	1.23	1.6
Csf2rb	0.63	0.63	1.26
Csf3	1.06	0.81	1.2
Cxcl1	0.83	0.02	1.16
Cxcl10	0.42	1.05	0.45
Cxcl3	0.45	0.2	1.2
Cxcl9	0.45	0.62	0.94
Egfr	1.17	0.58	0.8
Egr2	1.8	0.17	1.03
F3	0.72	0.81	0.92
F8	0.8	0.8	0.86
Fas	0.78	0.82	0.73
Faslg	0.71	0.6	0.71
Gadd45b	0.91	0.62	0.96
Icam1	0.45	0.83	0.88
Ifnb1	0.99	0.93	1.2
Ifng	1.1	1.23	1.6
Il12b	2.26	1.23	1.6
Il15	0.68	1.04	1.02
Il1a	0.78	0.84	0.51
Il1b	1.19	0.71	0.91
Il1r2	1.34	1.75	1.03
Il1rn	1.06	0.91	0.99
Il2	0.47	0.69	1.22
Il2ra	0.52	0.68	0.63
Il4	0.51	0.29	0.47
Il6	0.87	0.59	1.59
Ins2	0.01	0.02	1.3
Irf1	0.59	0.63	0.81
Lta	0.59	0.22	1.25
Ltb	1.23	0.92	0.64
Map2k6	0.81	0.87	0.97
Mitf	0.96	0.68	0.82
Mmp9	1.16	0.81	1.13
Myc	0.68	0.78	0.71
Myd88	0.76	0.7	0.88
Ncoa3	0.81	0.69	0.96
Nfkb1	0.81	0.72	0.99
Nfkb2	0.77	0.85	1
Nfkbia	0.81	0.63	1.01
Nqo1	1.09	0.82	1
Nr4a2	0.58	0.56	0.75
Pdgfb	0.86	0.65	0.79
Plau	1.57	0.93	1.46
Ptgs2	1.13	0.69	1.14
Rel	0.75	0.52	0.96
Rela	0.76	0.67	0.73
Sele	0.72	0.52	1.12
Selp	1.54	1.56	1.56
Snap25	1.53	0.86	1.28
Sod2	1.04	0.98	1.04
Stat1	0.91	0.88	0.93
Stat3	0.82	0.74	0.95
Stat5b	0.77	0.78	0.78
Tnf	1.02	0.75	0.93
Tnfrsf1b	0.32	0.4	1
Tnfsf10	0.98	0.8	0.65
Tp53	0.93	0.79	0.78
Traf2	0.86	0.72	0.85
Vcam1	0.67	0.69	0.87
Xiap	0.78	0.7	0.85

Mean fold changes (n = 3 measurements) of all 84 mRNA related to the NFκB pathway from qRT-PCR at different time points comparing the contralateral (nonsonicated) hemisphere with the sham-treated control.